Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery.
Sirogen™ is currently undergoing clinical trials to determine its safety and effectiveness in improving vascular access outcomes in patients requiring an arteriovenous fistula for hemodialysis.
Industry
Pharmaceutical Manufacturing, Other Ambulatory Health Care Services, Health Care and Social Assistance
HQ Location
105 Union Avenue
Cresskill, NJ 07626, US
Keywords
biopharmaceuticalhemodialysisvascular accesscombination product